Profile
Full Name
Tourmaline Bio, Inc.Ticker
NASDAQ: TRMLExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 7, 2021Indexes
Not includedEmployees
74Key Details
Price
$47.61(+0.02%)
Market cap
$1.22B(Small cap)
Last Dividend
$1.51
Annual revenue
$0.00(0.00% YoY)
Annual EPS
-$2.89(-225.82% YoY)
Next earnings date
Nov 13, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 14, 25 Guggenheim
BuyAug 14, 25 Chardan Capital
BuyMay 5, 25 HC Wainwright & Co.
BuyMay 5, 25 Chardan Capital
BuyApr 23, 25 Chardan Capital
BuyMar 14, 25 Wedbush
OutperformMar 14, 25 HC Wainwright & Co.
BuyMar 6, 25 Wedbush
OutperformFeb 24, 25 LifeSci Capital
OutperformDec 11, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Tourmaline Bio, Inc.?
- Does Tourmaline Bio, Inc. pay dividends?
- What sector is Tourmaline Bio, Inc. in?
- What industry is Tourmaline Bio, Inc. in?
- What country is Tourmaline Bio, Inc. based in?
- When did Tourmaline Bio, Inc. go public?
- Is Tourmaline Bio, Inc. in the S&P 500?
- Is Tourmaline Bio, Inc. in the NASDAQ 100?
- Is Tourmaline Bio, Inc. in the Dow Jones?
- When was Tourmaline Bio, Inc.'s last earnings report?
- When does Tourmaline Bio, Inc. report earnings?
What is the ticker symbol for Tourmaline Bio, Inc.?
The ticker symbol for Tourmaline Bio, Inc. is NASDAQ:TRML
Does Tourmaline Bio, Inc. pay dividends?
No, Tourmaline Bio, Inc. does not pay dividends
What sector is Tourmaline Bio, Inc. in?
Tourmaline Bio, Inc. is in the Healthcare sector
What industry is Tourmaline Bio, Inc. in?
Tourmaline Bio, Inc. is in the Biotechnology industry
What country is Tourmaline Bio, Inc. based in?
Tourmaline Bio, Inc. is headquartered in United States
When did Tourmaline Bio, Inc. go public?
Tourmaline Bio, Inc.'s initial public offering (IPO) was on May 7, 2021
Is Tourmaline Bio, Inc. in the S&P 500?
No, Tourmaline Bio, Inc. is not included in the S&P 500 index
Is Tourmaline Bio, Inc. in the NASDAQ 100?
No, Tourmaline Bio, Inc. is not included in the NASDAQ 100 index
Is Tourmaline Bio, Inc. in the Dow Jones?
No, Tourmaline Bio, Inc. is not included in the Dow Jones index
When was Tourmaline Bio, Inc.'s last earnings report?
Tourmaline Bio, Inc.'s most recent earnings report was on August 13, 2025
When does Tourmaline Bio, Inc. report earnings?
The next expected earnings date for Tourmaline Bio, Inc. is November 13, 2025